These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34426814)

  • 1. Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study.
    Chin ET; Leidner D; Zhang Y; Long E; Prince L; Schrag SJ; Verani JR; Wiegand RE; Alarid-Escudero F; Goldhaber-Fiebert JD; Studdert DM; Andrews JR; Salomon JA
    medRxiv; 2021 Aug; ():. PubMed ID: 34426814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study.
    Chin ET; Leidner D; Zhang Y; Long E; Prince L; Schrag SJ; Verani JR; Wiegand RE; Alarid-Escudero F; Goldhaber-Fiebert JD; Studdert DM; Andrews JR; Salomon JA
    Clin Infect Dis; 2022 Aug; 75(1):e838-e845. PubMed ID: 35083482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies.
    Ryckman T; Chin ET; Prince L; Leidner D; Long E; Studdert DM; Salomon JA; Alarid-Escudero F; Andrews JR; Goldhaber-Fiebert JD
    Lancet Public Health; 2021 Oct; 6(10):e760-e770. PubMed ID: 34364404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors.
    Chin ET; Ryckman T; Prince L; Leidner D; Alarid-Escudero F; Andrews JR; Salomon JA; Studdert DM; Goldhaber-Fiebert JD
    medRxiv; 2021 Mar; ():. PubMed ID: 33758868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons.
    Prince L; Long E; Studdert DM; Leidner D; Chin ET; Andrews JR; Salomon JA; Goldhaber-Fiebert JD
    JAMA Health Forum; 2022 Mar; 3(3):e220099. PubMed ID: 35977288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors.
    Chin ET; Ryckman T; Prince L; Leidner D; Alarid-Escudero F; Andrews JR; Salomon JA; Studdert DM; Goldhaber-Fiebert JD
    J Gen Intern Med; 2021 Oct; 36(10):3096-3102. PubMed ID: 34291377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
    Archer H; McCoy SI; Sears D; Kwan A; Kuersten M; Lewnard JA; Bertozzi SM
    Vaccine; 2024 Apr; 42(12):3057-3065. PubMed ID: 38584059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
    Pawlowski C; Lenehan P; Puranik A; Agarwal V; Venkatakrishnan AJ; Niesen MJM; O'Horo JC; Virk A; Swift MD; Badley AD; Halamka J; Soundararajan V
    Med; 2021 Aug; 2(8):979-992.e8. PubMed ID: 34223401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.
    Britton A; Jacobs Slifka KM; Edens C; Nanduri SA; Bart SM; Shang N; Harizaj A; Armstrong J; Xu K; Ehrlich HY; Soda E; Derado G; Verani JR; Schrag SJ; Jernigan JA; Leung VH; Parikh S
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(11):396-401. PubMed ID: 33735160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system.
    Ioannou GN; Locke ER; Green PK; Berry K
    EClinicalMedicine; 2022 Mar; 45():101326. PubMed ID: 35261970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
    Lutrick K; Rivers P; Yoo YM; Grant L; Hollister J; Jovel K; Khan S; Lowe A; Baccam Z; Hanson H; Olsho LEW; Fowlkes A; Caban-Martinez AJ; Porter C; Yoon S; Meece J; Gaglani M; Burns J; Mayo Lamberte J; Nakayima Miiro F; Bissonnette A; LeClair L; Kutty PK; Romine JK; Stefanski E; Edwards LJ; Ellingson K; Gerald JK; Bedrick EJ; Madhivanan P; Krupp K; Gerald LB; Thompson M; Burgess JL
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1761-1765. PubMed ID: 34968373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
    Hammerman A; Sergienko R; Friger M; Beckenstein T; Peretz A; Netzer D; Yaron S; Arbel R
    N Engl J Med; 2022 Mar; 386(13):1221-1229. PubMed ID: 35172072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.